Renee Gala joins a short list of female biopharma chief executives as she is set to take the reins at Jazz Pharmaceuticals, ...

The US president has given manufacturers as little as one year to relocate production back to the US or face 200% tariffs.

Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 billion.

“This agreement is another illustration of how we aim to enrich our discovery engine with strategic technology-focused collaborations,” said Belén Garijo, member of the executive board and ...

Yesterday, I had the opportunity to meet our SpringWorks Therapeutics team in Stamford, CT, and personally welcome them to Merck Group. It was a very energizing meeting and a powerful reminder of ...

With US President Donald Trump threatening 200 percent tariffs on imported pharmaceutical products within as little as one year, the industry is on red alert. That’s the timeframe Trump has ...

While globalization is certainly not perfect, our CEO Belén Garijo says ‘there is no global world without China'." Data from the Ministry of Commerce showed that a total of 42,108 new foreign-invested ...

They are the process solutions business of life science, new healthcare products, and the semiconductor solutions business of electronics. The Asia Pacific contributed around 36 percent to that ...

With pharma’s finger on the M&A button, three of the biggest deals of the year are breadcrumbs that could lead to a full-on resurgence.